Martin H. Prins - Concepedia

Author

Martin H. Prins

Also Known As

Abraham van den Ende, Antonio Marchiori, Douwe H. Biesma, Frank Leebeek, Harry Buller, Harry Büller, Henk van Weert, Hugo ten Cate, Jan van der Meer, Katharina Mueller

507

Publications

51.4K

Citations

109

H-Index

217

Concepts

All Affiliations

Maastricht University Maastricht University Medical Centre Amsterdam UMC Location University of Amsterdam University of Amsterdam Bayer (Germany)

About

Martin H. Prins is an author at Maastricht University specializing in medicine, thrombosis, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	58	101	9.8K
2	Public Health	29	36	5.2K
3	Health Sciences	21	25	3.2K
4	Social Sciences	2	2	95
5	Engineering	1	1	2.3K

Martin H. Prins

270

Publications

39.2K

Citations

H-Index

Page 1

	Year	Citations
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer Agnes Lee, Mark N. Levine, Ross Baker, New England Journal of Medicine	2003	2.5K
The diagnostic odds ratio: a single indicator of test performance Afina S. Glas, Jeroen G. Lijmer, Martin H. Prins, Journal of Clinical Epidemiology ReliabilityDiagnostic Odds RatioEngineeringTest DevelopmentSoftware Testing	2003	2.3K
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis Paolo Prandoni, Anthonie W.A. Lensing, Andrea Piccioli, Blood	2002	1.8K
Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism Vittorio Pengo, Anthonie W.A. Lensing, Martin H. Prins, New England Journal of Medicine	2004	1.8K
Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home Maria M.W. Koopman, Paolo Prandoni, Franco Piovella, New England Journal of Medicine	1996	1.1K
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial Bengt I. Eriksson, Ola E. Dahl, Nadia Rosencher, The Lancet ThrombosisVenous DiseaseVenous ThrombosisVersus EnoxaparinHip Arthroplasty	2007	1.1K
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial Alexander T Cohen, Bruce L. Davidson, Alexander Gallus, BMJ	2006	852
Atrial fibrillation management: a prospective survey in ESC Member Countries Robby Nieuwlaat, Alessandro Capucci, A. John Camm, European Heart Journal	2005	822
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism Jeffrey I. Weitz, Anthonie W.A. Lensing, Martin H. Prins, New England Journal of Medicine	2017	750
Incidence of Recurrent Thromboembolic and Bleeding Complications Among Patients With Venous Thromboembolism in Relation to Both Malignancy and Achieved International Normalized Ratio: A Retrospective Analysis Barbara A. Hutten, Martin H. Prins, Michael Gent, Journal of Clinical Oncology	2000	747

Page 1